Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial (vol 36, pg 2508, 2013)

被引：0
作者：
Tomita, K.
机构：
来源：
DIABETES CARE | 2013年 / 36卷 / 12期
关键词：
D O I：
10.2337/dc13-er12b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4172 / 4172
页数：1
相关论文
共 50 条
[41]   Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study [J].
Bosi, E. ;
Ellis, G. C. ;
Wilson, C. A. ;
Fleck, P. R. .
DIABETES OBESITY & METABOLISM, 2011, 13 (12) :1088-1096
[42]   Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes (vol 36, pg 2559, 2013) [J].
Henry, Robert R. ;
Rosenstock, Julio ;
Logan, Douglas K. ;
Alessi, Thomas R. ;
Luskey, Kenneth ;
Baron, Michelle A. .
DIABETES CARE, 2014, 37 (01) :312-312
[43]   Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial [J].
Kovacs, C. S. ;
Seshiah, V. ;
Swallow, R. ;
Jones, R. ;
Rattunde, H. ;
Woerle, H. J. ;
Broedl, U. C. .
DIABETES OBESITY & METABOLISM, 2014, 16 (02) :147-158
[44]   Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week,double-blind, placebo-controlled trial [J].
Strojek, K. ;
Yoon, K. H. ;
Hruba, V. ;
Elze, M. ;
Langkilde, A. M. ;
Parikh, S. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 :S16-S26
[45]   Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial [J].
Strojek, K. ;
Yoon, K. H. ;
Hruba, V. ;
Elze, M. ;
Langkilde, A. M. ;
Parikh, S. .
DIABETES OBESITY & METABOLISM, 2011, 13 (10) :928-938
[46]   HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin [J].
Ahren, Bo ;
Johnson, Susan L. ;
Stewart, Murray ;
Cirkel, Deborah T. ;
Yang, Fred ;
Perry, Caroline ;
Feinglos, Mark N. .
DIABETES CARE, 2014, 37 (08) :2141-2148
[47]   Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy (vol 26, pg 2034, 2004) [J].
Malone, JK .
CLINICAL THERAPEUTICS, 2005, 27 (07) :1112-1112
[48]   Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial (vol 12, 104, 2023) [J].
Zakaraia, Haitham G. ;
Salem, Heba F. ;
Mostafa, Mostafa A. A. ;
Ali, Ahmed M. ;
Rabea, Hoda M. .
BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2024, 13 (01)
[49]   Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia) [J].
Pan, Chang Yu ;
Han, Ping ;
Liu, Xiaoming ;
Yan, Shengli ;
Feng, Ping ;
Zhou, Zhiguang ;
Lv, Xiaofeng ;
Tian, Hui ;
Kui, Yang Jin ;
Su, Benli ;
Shang, Shuhua ;
Niemoeller, Elisabeth .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) :726-735
[50]   Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial [J].
Yokoh, Hidetaka ;
Kobayashi, Kazuki ;
Sato, Yasunori ;
Takemoto, Minoru ;
Uchida, Daigaku ;
Kanatsuka, Azuma ;
Kuribayashi, Nobuichi ;
Terano, Takashi ;
Hashimoto, Naotake ;
Sakurai, Kenichi ;
Hanaoka, Hideki ;
Ishikawa, Ko ;
Onishi, Shunichiro ;
Yokote, Koutaro .
JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (02) :182-191
12345